Thermo Fisher Scientific (TMO) Benefits on Broad-Based Recovery Across Life-Science Markets
Broyhill Asset Management, a Charlotte-based firm, issued its third-quarter 2026 investor letter. The letter can be downloaded here.
Thermo Fisher Scientific Inc. (TMO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Egerton Capital Limited John Armitage | 198,227 | $133,813,136 | 1.36% | |
| 2. | Sivik Global Healthcare Krishen Sud | 8,500 | $5,737,925 | +7% | 3.28% |
| 3. | Bailard Inc Thomas Bailard | 6,143 | $4,147,122 | +2% | 0.08% |
| 4. | Lee Munder Capital Group Lee Munder | 2,304 | $1,555,315 | +1% | 0.08% |
| 5. | Skylands Capital Charles Paquelet | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $535.93 | 4 | $2,143.73 | 14,268 | 2024-12-09 | Filing | |
| $555.89 | 16 | $8,894.24 | 14,264 | 2024-11-07 | Filing | |
| $526.15 | 4 | $2,104.60 | 13,101 | 2023-06-26 | Filing | |
| $134.16 | 1,000 | $134,160.00 | 14,636 | 2015-12-11 | Filing | |
| $45.84 | 36 | $1,650.24 | 25,914 | 2010-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $614.38 | 3,733 | $2,293,480.54 | 23,216 | 2026-08-31 | Filing | |
| $614.38 | 400 | $245,752.00 | 23,216 | 2026-08-31 | Filing | |
| $628.74 | 62 | $38,981.88 | 123,925 | 2026-08-24 | Filing | |
| $628.01 | 79 | $49,612.79 | 123,987 | 2026-08-24 | Filing | |
| $626.59 | 33 | $20,677.47 | 124,066 | 2026-08-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,463,282 | $987,788,514 | 2.92% | |
| 2. | 716,890 | $483,936,595 | 0.58% | |
| 3. | 528,090 | $356,487,161 | 0.78% | |
| 4. | 454,341 | $306,702,529 | 2.83% | |
| 5. | 314,588 | $212,362,629 | 3.06% |
News See All
Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences Recovery
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q3 2026 investor letter for its “Large Cap Strategy”. The letter can be downloaded here.
Academic and Government Spending Powers Thermo Fisher (TMO)
Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q3 2026 investor letter for the “Focused Equity Strategy.” The letter can be downloaded here.
Biotech and Pharma Rebound Strengthen Thermo’s (TMO) Organic Growth
Lindsell Train Ltd, an investment management company, has released its "Lindsell Train Global Equity Fund" third-quarter 2026 investor letter. The letter can be downloaded here.
Thermo Fisher Stock Trades at a Premium. Can Its Earnings Keep Up?
Thermo Fisher Scientific, Inc. (NYSE:TMO) is having a good year, with shares surging by over 11% so far. The stock's outperformance has come as the life-sciences tools market shows signs of recovery.
Thermo Fisher Scientific (TMO): Strong Q3 Guidance and Broadening Demand Support Multi-Year Outlook
ClearBridge Investments, a global equity manager, recently published third-quarter 2026 commentary for its “Large Cap Growth Strategy”. The letter can be downloaded here.
JPMorgan Adds American Express, Liberty Energy, and Thermo Fisher to October Stock Picks List. Here’s Why.
JPMorgan ($JPM) refreshed its list of favorite stock ideas for October, adding five new companies across its value and growth strategies. The updat...
Thermo Fisher (TMO) Is Turning Innovation Into Recurring Revenue. Can Margins Follow?
On September 23, Thermo Fisher Scientific Inc.
10 Best Healthcare Stocks to Buy According to Hedge Funds
Healthcare has rarely been short of investment opportunities, but deciding where to look has become more complicated.
Gilead vs. Thermo Fisher: Which Life Sciences Stock has the Stronger Growth Outlook?
Gilead Sciences, Inc. (NASDAQ:GILD) and Thermo Fisher Scientific Inc. (NYSE:TMO) are benefiting from two very different sources of growth.
Hedge Fund Resource Center